Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan; Program in Molecular Medicine, National Yang-Ming University and Academia Sinica, Taipei, Taiwan.
Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan; Program in Molecular Medicine, National Yang-Ming University and Academia Sinica, Taipei, Taiwan.
Phytomedicine. 2021 Jan;80:153384. doi: 10.1016/j.phymed.2020.153384. Epub 2020 Oct 16.
Ling Zhi-8 (LZ-8) and GMI are two fungal immunomodulatory proteins (FIPs) with a similar structure and amino acid sequence and are respectively obtained from the medicinal mushroom Ganoderma lucidum and Ganoderma microsporum. They present the anti-cancer progression and metastasis. We previously demonstrated that LZ-8 reduces the tumor progression in lung cancer LLC1 cell-bearing mouse. However, it is unclear whether these FIPs induce changes in the protein expression profile in cancer cells and the mechanism for such a process is not defined.
This study determines the changes in the proteomic profile for tumor lesions of LLC1 cell-bearing mouse received with LZ-8 and the potential mechanism for FIPs in anti-lung cancer cells.
The proteomic profile of tumor lesions was determined using two-dimensional electrophoresis and a LTQ-OrbitrapXL mass spectrometer (LC-MS/MS). The biological processes and the signaling pathway enrichment analysis were performed using Ingenuity Pathway Analysis (IPA). The differentially expressed proteins were verified by Western blot. Cell viability was determined by MTT assay. Cell morphology was characterized using electron microscopy. Migration was detected using the Transwell assay. The apoptotic response was determined using Western blot and flow cytometry.
Obtained results showed that 21 proteins in the tumor lesions exhibited differential (2-fold change, p < 0.05) expression between PBS and LZ-8 treatment groups. LZ-8-induced changes in the proteomic profile that may relate to protein degradation pathways. Specifically, three heat shock proteins (HSPs), HSP60, 70 and 90, were significantly downregulated in tumor lesions of LLC1-bearing mouse received with LZ-8. Both LZ-8 and GMI reduced the protein levels for these HSPs in lung cancer cells. Functional studies showed that they inhibited cell migration but effectively induced apoptotic response in LLC1 cells in vitro. In addition, the inhibitors of HSP60 and HSP70 effectively inhibited cell migration and decreased cell viability of LLC1 cells.
LZ-8 induced changes in the proteomic profile of tumor lesions which may regulate the HSPs-related cell viability. Moreover, inhibition of HSPs may be related to the anti-lung cancer activity.
灵芝-8(LZ-8)和 GMI 是两种结构和氨基酸序列相似的真菌免疫调节蛋白(FIP),分别从药用蘑菇灵芝和灵芝中获得。它们具有抗癌进展和转移的作用。我们之前的研究表明,LZ-8 可降低肺癌 LLC1 细胞荷瘤小鼠的肿瘤进展。然而,目前尚不清楚这些 FIP 是否会引起癌细胞中蛋白质表达谱的变化,并且该过程的机制尚未确定。
本研究旨在确定接受 LZ-8 治疗的 LLC1 细胞荷瘤小鼠肿瘤病变的蛋白质组学谱的变化,以及 FIP 在抗肺癌细胞中的潜在机制。
使用二维电泳和 LTQ-OrbitrapXL 质谱仪(LC-MS/MS)测定肿瘤病变的蛋白质组学谱。使用 IPA 进行生物过程和信号通路富集分析。通过 Western blot 验证差异表达蛋白。通过 MTT 测定法测定细胞活力。使用电子显微镜观察细胞形态。使用 Transwell 测定法检测迁移。通过 Western blot 和流式细胞术检测凋亡反应。
研究结果表明,PBS 和 LZ-8 处理组之间,肿瘤病变中有 21 种蛋白质的表达存在差异(2 倍变化,p<0.05)。LZ-8 诱导的蛋白质组学谱变化可能与蛋白质降解途径有关。具体来说,在接受 LZ-8 治疗的 LLC1 荷瘤小鼠的肿瘤病变中,三种热休克蛋白(HSPs)HSP60、70 和 90 的表达明显下调。LZ-8 和 GMI 均降低了肺癌细胞中这些 HSPs 的蛋白水平。功能研究表明,它们抑制 LLC1 细胞的迁移,但有效地诱导了细胞凋亡。此外,HSP60 和 HSP70 的抑制剂有效地抑制了 LLC1 细胞的迁移并降低了其细胞活力。
LZ-8 诱导了肿瘤病变的蛋白质组学谱变化,可能调节 HSPs 相关的细胞活力。此外,抑制 HSPs 可能与抗肺癌活性有关。